OBJECTIVES: The objective of this study was to evaluate the efficacy of a new surgical procedure for @entity7364 ( @entity7364 ). This surgery involves the bilateral selective division of the adductor branches of the recurrent laryngeal nerves with immediate reinnervation of the distal nerve trunks with branches of the ansa cervicalis (selective denervation-reinnervation). METHODS: Our first six @entity1 to undergo this procedure were enrolled in the study. All @entity1 suffered from @entity7364 and had previously received botulinum toxin A (Botox, Allergen, Markham, ON) therapy. @entity1 were recorded preoperatively and all underwent the same surgical procedure performed by the same lead surgeon. All @entity1 were surveyed postoperatively and then re-recorded. Expert and untrained judges undertook perceptual evaluation of @entity1740 . Voice samples were also objectively evaluated for @entity6724 . RESULTS: No major surgical complications were noted. @entity1 satisfaction was excellent, and five of the six @entity1 no longer require botulinum toxin therapy. In five of the six @entity1 , the majority of untrained and expert listeners perceived the postoperative voice to be superior. Objectively, the rate of @entity6724 was also reduced in five of the six @entity1 .

Selective denervation: reinnervation for the control of XXXX .

@entity7364 :: ('MESH:D055154', 'Disease') :: ['AddSD', 'adductor spasmodic dysphonia'] @entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'Patient'] @entity6724 :: ('MESH:D019457', 'Disease') :: ['aphonic voice breaks'] @entity1740 :: ('MESH:D014832', 'Disease') :: ['voice quality']
@entity7364 :: (MESH:D055154,Disease) :: ['adductor spasmodic dysphonia']
